(Q54527295)
Statements
Long-term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study. (English)
Chiaki Nakaseko
Noriko Usui
Kazunori Ohnishi
Jin Takeuchi
Shin Fujisawa
Tadashi Nagai
Hirohito Yamazaki
Tetsuzo Tauchi
Kiyotoshi Imai
Naoki Mori
Fumiharu Yagasaki
Yasuhiro Maeda
Yasushi Miyazaki
Koichi Miyamura
Hitoshi Kiyoi
Shigeki Ohtake
Tomoki Naoe
Japan Adult Leukemia Study Group
16 April 2012
103
6
1071-1078
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference